Geoepidemiology, Clinical Manifestations and Outcome of Primary Biliary Cholangitis in Greece
Overview
Authors
Affiliations
Background & Aims: Primary biliary cholangitis (PBC) is a disease with rising prevalence and considerable geographical variation. To describe the prevalence, spatial and time distribution, baseline characteristics, response to treatment, outcome and the validity of GLOBE score in a large cohort of Greek PBC patients as an independent validation of this score has not been done so far.
Methods: The last 16years, 482 PBC patients (86.5% females) were evaluated and analysed retrospectively, using a prospectively collected database. Special attention was paid to the assessment of treatment response according to GLOBE score.
Results: Age at initial evaluation was 56.3±13.7years. Among 432 Thessaly residents, prevalence was 582/million (non-homogeneous distribution). Nineteen districts showed a prevalence >800/million. Symptomatic disease onset could be identified in 91 patients, with a significant peak during spring (P=0.03). At diagnosis, 43.6% were asymptomatic and 16.2% cirrhotic. Male sex (P=0.02), older age (P<0.001), alcohol consumption (P<0.01) and concomitant liver disease (P<0.001) were negative prognostic factors for cirrhosis. During a median [interquartile range, range] follow-up of 5.1 (7.8, 15.7) years, 62 patients died or underwent liver transplantation. Patients with GLOBE score>0.30 had significantly worse prognosis (P<0.001) with 5-, 10-, and 15-year survival rates of 84%, 50% and 42%.
Conclusions: There is increased PBC prevalence in Thessaly with remarkable geographic clustering and seasonal variability. PBC is diagnosed at early stages although males had a more advanced disease. GLOBE score applies perfectly in Greek patients and this will likely help detecting patients that may benefit from new therapies.
Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database.
Lim J, Kim H Orphanet J Rare Dis. 2024; 19(1):178.
PMID: 38685058 PMC: 11057181. DOI: 10.1186/s13023-024-03086-0.
Rigopoulou E, Bakarozi M, Dimas I, Galanis K, Lygoura V, Gatselis N J Transl Int Med. 2023; 11(3):246-254.
PMID: 37818155 PMC: 10561069. DOI: 10.2478/jtim-2023-0098.
Risk Stratification in Primary Biliary Cholangitis.
Martini F, Balducci D, Mancinelli M, Buzzanca V, Fracchia E, Tarantino G J Clin Med. 2023; 12(17).
PMID: 37685780 PMC: 10488776. DOI: 10.3390/jcm12175713.
Zhao Y, Wei S, Chen L, Zhou X, Ma X Front Immunol. 2023; 14:1164202.
PMID: 37457696 PMC: 10349375. DOI: 10.3389/fimmu.2023.1164202.
Ismail A, Kennedy L, Francis H Am J Pathol. 2023; 193(10):1355-1362.
PMID: 37422150 PMC: 10548272. DOI: 10.1016/j.ajpath.2023.06.010.